Adaptive Biotechnologies Corp
(ADPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,612 | 90,030 | 217,552 | 76,412 | 114,805 |
| Marketable Securities | 346,083 | 408,166 | 290,527 | 307,326 | 248,757 |
| Receivables | 30,972 | 40,057 | 26,549 | 23,712 | 22,518 |
| Inventories | 19,874 | 14,453 | 17,345 | 18,778 | 21,002 |
| TOTAL | $501,333 | $562,146 | $564,380 | $438,575 | $419,120 |
| Non-Current Assets | |||||
| PPE Net | 81,294 | 83,447 | 86,662 | 86,852 | 85,994 |
| Investments And Advances | 0 | 0 | 19,698 | 66,928 | 137,110 |
| Intangibles | 125,380 | 125,799 | 126,228 | 126,656 | 127,079 |
| Other Non-Current Assets | 83,456 | 85,225 | 87,240 | 87,622 | 88,890 |
| TOTAL | $290,130 | $294,471 | $319,828 | $368,058 | $439,073 |
| Total Assets | $791,463 | $856,617 | $884,208 | $806,633 | $858,193 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,333 | 8,084 | 4,163 | 2,720 | 5,959 |
| Accrued Expenses | 14,161 | 28,359 | 23,435 | 19,219 | 17,058 |
| TOTAL | $90,101 | $109,788 | $104,018 | $111,468 | $115,066 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 60,320 | 64,115 | 67,892 | 80,914 | 83,504 |
| Other Non-Current Liabilities | 223,503 | 224,173 | 225,114 | 102,765 | 105,038 |
| TOTAL | $277,410 | $282,731 | $292,376 | $176,849 | $189,872 |
| Total Liabilities | $367,511 | $392,519 | $396,394 | $288,317 | $304,938 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 144,311 | 143,227 | 143,012 | 142,873 | 142,228 |
| Common Shares | 14 | 14 | 14 | 14 | 14 |
| Retained earnings | -976,781 | -919,082 | -878,954 | -833,673 | -781,627 |
| Other shareholders' equity | -1,973 | -4,183 | -5,997 | -5,788 | -4,733 |
| TOTAL | $423,952 | $464,098 | $487,814 | $518,316 | $553,255 |
| Total Liabilities And Equity | $791,463 | $856,617 | $884,208 | $806,633 | $858,193 |